Allscripts

Latest stories

28d
MedCity News
BioMarin pulls plug on $680M Duchenne drug, Valeant's Pearson cashes inWell’s advisory board. — American Well Stop us if you’ve heard this before: an
BioMarin pulls plug on $680M Duchenne drug, Valeant's Pearson cashes in
MedCity News / Posted 28 days ago
Well’s advisory board. — American Well Stop us if you’ve heard this before: an EHR vendor executive, in this case, Allscripts President Rick Poulton, said that vendors need to start innovating around interoperability. — Healthcare IT... Read more

People in this news